カテゴリー： Market Monitor Global, 世界, 医療/バイオ

タウロドンティズム治療の世界市場見通し2023年-2029年

◆英語タイトル：Taurodontism Treatment Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2517）◆商品コード：MMG23FB2517
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のタウロドンティズム治療市場規模と予測を収録しています。・世界のタウロドンティズム治療市場：売上、2018年-2023年、2024年-2029年
・世界のタウロドンティズム治療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のタウロドンティズム治療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「外科治療」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

タウロドンティズム治療のグローバル主要企業は、Pfizer Inc.、AbbVie Inc、Johnson & Johnson Private Limited、Novartis AG、Abbott Laboratories、Bausch Health Companies Inc、Mallinckrodt、Regeneron Pharmaceuticals Inc、Swedish Orphan Biovitrum ABなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、タウロドンティズム治療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のタウロドンティズム治療市場：タイプ別、2018年-2023年、2024年-2029年
世界のタウロドンティズム治療市場：タイプ別市場シェア、2022年
・外科治療、内科治療、その他

世界のタウロドンティズム治療市場：用途別、2018年-2023年、2024年-2029年
世界のタウロドンティズム治療市場：用途別市場シェア、2022年
・病院、在宅医療、専門クリニック、その他

世界のタウロドンティズム治療市場：地域・国別、2018年-2023年、2024年-2029年
世界のタウロドンティズム治療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるタウロドンティズム治療のグローバル売上、2018年-2023年
・主要企業におけるタウロドンティズム治療のグローバル売上シェア、2022年
・主要企業におけるタウロドンティズム治療のグローバル販売量、2018年-2023年
・主要企業におけるタウロドンティズム治療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer Inc.、AbbVie Inc、Johnson & Johnson Private Limited、Novartis AG、Abbott Laboratories、Bausch Health Companies Inc、Mallinckrodt、Regeneron Pharmaceuticals Inc、Swedish Orphan Biovitrum AB

*************************************************************

・調査・分析レポートの概要
タウロドンティズム治療市場の定義
市場セグメント
世界のタウロドンティズム治療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のタウロドンティズム治療市場規模
世界のタウロドンティズム治療市場規模：2022年 VS 2029年
世界のタウロドンティズム治療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのタウロドンティズム治療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のタウロドンティズム治療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：外科治療、内科治療、その他
タウロドンティズム治療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、在宅医療、専門クリニック、その他
タウロドンティズム治療の用途別グローバル売上・予測

・地域別市場分析
地域別タウロドンティズム治療市場規模 2022年と2029年
地域別タウロドンティズム治療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer Inc.、AbbVie Inc、Johnson & Johnson Private Limited、Novartis AG、Abbott Laboratories、Bausch Health Companies Inc、Mallinckrodt、Regeneron Pharmaceuticals Inc、Swedish Orphan Biovitrum AB
...

This report aims to provide a comprehensive presentation of the global market for Taurodontism Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Taurodontism Treatment. This report contains market size and forecasts of Taurodontism Treatment in global, including the following market information:
Global Taurodontism Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Taurodontism Treatment Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Taurodontism Treatment companies in 2022 (%)
The global Taurodontism Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Surgical Treatment Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Taurodontism Treatment include Pfizer Inc., AbbVie Inc, Johnson & Johnson Private Limited, Novartis AG, Abbott Laboratories, Bausch Health Companies Inc, Mallinckrodt, Regeneron Pharmaceuticals Inc and Swedish Orphan Biovitrum AB, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Taurodontism Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Taurodontism Treatment Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Taurodontism Treatment Market Segment Percentages, by Type, 2022 (%)
Surgical Treatment
Medical Treatement
Others
Global Taurodontism Treatment Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Taurodontism Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Taurodontism Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Taurodontism Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Taurodontism Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Taurodontism Treatment revenues share in global market, 2022 (%)
Key companies Taurodontism Treatment sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Taurodontism Treatment sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
AbbVie Inc
Johnson & Johnson Private Limited
Novartis AG
Abbott Laboratories
Bausch Health Companies Inc
Mallinckrodt
Regeneron Pharmaceuticals Inc
Swedish Orphan Biovitrum AB
Outline of Major Chapters:
Chapter 1: Introduces the definition of Taurodontism Treatment, market overview.
Chapter 2: Global Taurodontism Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Taurodontism Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Taurodontism Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Taurodontism Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Taurodontism Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Taurodontism Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Taurodontism Treatment Overall Market Size
2.1 Global Taurodontism Treatment Market Size: 2022 VS 2029
2.2 Global Taurodontism Treatment Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Taurodontism Treatment Sales: 2018-2029
3 Company Landscape
3.1 Top Taurodontism Treatment Players in Global Market
3.2 Top Global Taurodontism Treatment Companies Ranked by Revenue
3.3 Global Taurodontism Treatment Revenue by Companies
3.4 Global Taurodontism Treatment Sales by Companies
3.5 Global Taurodontism Treatment Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Taurodontism Treatment Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Taurodontism Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Taurodontism Treatment Players in Global Market
3.8.1 List of Global Tier 1 Taurodontism Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Taurodontism Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Taurodontism Treatment Market Size Markets, 2022 & 2029
4.1.2 Surgical Treatment
4.1.3 Medical Treatement
4.1.4 Others
4.2 By Type – Global Taurodontism Treatment Revenue & Forecasts
4.2.1 By Type – Global Taurodontism Treatment Revenue, 2018-2023
4.2.2 By Type – Global Taurodontism Treatment Revenue, 2024-2029
4.2.3 By Type – Global Taurodontism Treatment Revenue Market Share, 2018-2029
4.3 By Type – Global Taurodontism Treatment Sales & Forecasts
4.3.1 By Type – Global Taurodontism Treatment Sales, 2018-2023
4.3.2 By Type – Global Taurodontism Treatment Sales, 2024-2029
4.3.3 By Type – Global Taurodontism Treatment Sales Market Share, 2018-2029
4.4 By Type – Global Taurodontism Treatment Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Taurodontism Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Homecare
5.1.4 Specialty Clinics
5.1.5 Others
5.2 By Application – Global Taurodontism Treatment Revenue & Forecasts
5.2.1 By Application – Global Taurodontism Treatment Revenue, 2018-2023
5.2.2 By Application – Global Taurodontism Treatment Revenue, 2024-2029
5.2.3 By Application – Global Taurodontism Treatment Revenue Market Share, 2018-2029
5.3 By Application – Global Taurodontism Treatment Sales & Forecasts
5.3.1 By Application – Global Taurodontism Treatment Sales, 2018-2023
5.3.2 By Application – Global Taurodontism Treatment Sales, 2024-2029
5.3.3 By Application – Global Taurodontism Treatment Sales Market Share, 2018-2029
5.4 By Application – Global Taurodontism Treatment Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Taurodontism Treatment Market Size, 2022 & 2029
6.2 By Region – Global Taurodontism Treatment Revenue & Forecasts
6.2.1 By Region – Global Taurodontism Treatment Revenue, 2018-2023
6.2.2 By Region – Global Taurodontism Treatment Revenue, 2024-2029
6.2.3 By Region – Global Taurodontism Treatment Revenue Market Share, 2018-2029
6.3 By Region – Global Taurodontism Treatment Sales & Forecasts
6.3.1 By Region – Global Taurodontism Treatment Sales, 2018-2023
6.3.2 By Region – Global Taurodontism Treatment Sales, 2024-2029
6.3.3 By Region – Global Taurodontism Treatment Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Taurodontism Treatment Revenue, 2018-2029
6.4.2 By Country – North America Taurodontism Treatment Sales, 2018-2029
6.4.3 US Taurodontism Treatment Market Size, 2018-2029
6.4.4 Canada Taurodontism Treatment Market Size, 2018-2029
6.4.5 Mexico Taurodontism Treatment Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Taurodontism Treatment Revenue, 2018-2029
6.5.2 By Country – Europe Taurodontism Treatment Sales, 2018-2029
6.5.3 Germany Taurodontism Treatment Market Size, 2018-2029
6.5.4 France Taurodontism Treatment Market Size, 2018-2029
6.5.5 U.K. Taurodontism Treatment Market Size, 2018-2029
6.5.6 Italy Taurodontism Treatment Market Size, 2018-2029
6.5.7 Russia Taurodontism Treatment Market Size, 2018-2029
6.5.8 Nordic Countries Taurodontism Treatment Market Size, 2018-2029
6.5.9 Benelux Taurodontism Treatment Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Taurodontism Treatment Revenue, 2018-2029
6.6.2 By Region – Asia Taurodontism Treatment Sales, 2018-2029
6.6.3 China Taurodontism Treatment Market Size, 2018-2029
6.6.4 Japan Taurodontism Treatment Market Size, 2018-2029
6.6.5 South Korea Taurodontism Treatment Market Size, 2018-2029
6.6.6 Southeast Asia Taurodontism Treatment Market Size, 2018-2029
6.6.7 India Taurodontism Treatment Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Taurodontism Treatment Revenue, 2018-2029
6.7.2 By Country – South America Taurodontism Treatment Sales, 2018-2029
6.7.3 Brazil Taurodontism Treatment Market Size, 2018-2029
6.7.4 Argentina Taurodontism Treatment Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Taurodontism Treatment Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Taurodontism Treatment Sales, 2018-2029
6.8.3 Turkey Taurodontism Treatment Market Size, 2018-2029
6.8.4 Israel Taurodontism Treatment Market Size, 2018-2029
6.8.5 Saudi Arabia Taurodontism Treatment Market Size, 2018-2029
6.8.6 UAE Taurodontism Treatment Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Taurodontism Treatment Major Product Offerings
7.1.4 Pfizer Inc. Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 AbbVie Inc
7.2.1 AbbVie Inc Company Summary
7.2.2 AbbVie Inc Business Overview
7.2.3 AbbVie Inc Taurodontism Treatment Major Product Offerings
7.2.4 AbbVie Inc Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.2.5 AbbVie Inc Key News & Latest Developments
7.3 Johnson & Johnson Private Limited
7.3.1 Johnson & Johnson Private Limited Company Summary
7.3.2 Johnson & Johnson Private Limited Business Overview
7.3.3 Johnson & Johnson Private Limited Taurodontism Treatment Major Product Offerings
7.3.4 Johnson & Johnson Private Limited Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Private Limited Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Taurodontism Treatment Major Product Offerings
7.4.4 Novartis AG Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Taurodontism Treatment Major Product Offerings
7.5.4 Abbott Laboratories Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.5.5 Abbott Laboratories Key News & Latest Developments
7.6 Bausch Health Companies Inc
7.6.1 Bausch Health Companies Inc Company Summary
7.6.2 Bausch Health Companies Inc Business Overview
7.6.3 Bausch Health Companies Inc Taurodontism Treatment Major Product Offerings
7.6.4 Bausch Health Companies Inc Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.6.5 Bausch Health Companies Inc Key News & Latest Developments
7.7 Mallinckrodt
7.7.1 Mallinckrodt Company Summary
7.7.2 Mallinckrodt Business Overview
7.7.3 Mallinckrodt Taurodontism Treatment Major Product Offerings
7.7.4 Mallinckrodt Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.7.5 Mallinckrodt Key News & Latest Developments
7.8 Regeneron Pharmaceuticals Inc
7.8.1 Regeneron Pharmaceuticals Inc Company Summary
7.8.2 Regeneron Pharmaceuticals Inc Business Overview
7.8.3 Regeneron Pharmaceuticals Inc Taurodontism Treatment Major Product Offerings
7.8.4 Regeneron Pharmaceuticals Inc Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.8.5 Regeneron Pharmaceuticals Inc Key News & Latest Developments
7.9 Swedish Orphan Biovitrum AB
7.9.1 Swedish Orphan Biovitrum AB Company Summary
7.9.2 Swedish Orphan Biovitrum AB Business Overview
7.9.3 Swedish Orphan Biovitrum AB Taurodontism Treatment Major Product Offerings
7.9.4 Swedish Orphan Biovitrum AB Taurodontism Treatment Sales and Revenue in Global (2018-2023)
7.9.5 Swedish Orphan Biovitrum AB Key News & Latest Developments
8 Global Taurodontism Treatment Production Capacity, Analysis
8.1 Global Taurodontism Treatment Production Capacity, 2018-2029
8.2 Taurodontism Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Taurodontism Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Taurodontism Treatment Supply Chain Analysis
10.1 Taurodontism Treatment Industry Value Chain
10.2 Taurodontism Treatment Upstream Market
10.3 Taurodontism Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Taurodontism Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ タウロドンティズム治療の世界市場見通し2023年-2029年(Taurodontism Treatment Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ヘイウェル症候群治療のグローバル市場展望 2023年-2029年：分子遺伝学的検査、皮膚生検、出生前診断
  • 四肢麻痺治療の世界市場見通し2023年-2029年
  • 非結核性抗酸菌治療の世界市場見通し2023年-2029年
  • 血液腫瘍治療の世界市場見通し2023年-2029年
  • 痔用治療器具の世界市場見通し2023年-2029年